Trudy Lieberman: Misleading Medicare sales pitches are everywhere

0
1519
Trudy Lieberman

It seems that nothing ever changes when it comes to hawking insurance to fill the gaps in Medicare coverage for seniors. The fervent sales pitches, the misinformation and the incomplete and deceptive information continue to proliferate.

For the last several weeks I’ve heard ad after ad, particularly on the TV news shows, urging older viewers to call toll-free numbers to learn about the latest and greatest Medicare Advantage plans. Retired football star Joe Namath says you need to “get everything you’re entitled to.” Namath rattles off a bunch of extra benefits MA plans offer — dental, vision, hearing, prescription drug coverage — “all at no extra cost.” He urges viewers to “call the number on your screen now. It’s free.”

These are new benefits the government has allowed private insurers to sell in the hope of getting more seniors to leave traditional Medicare in favor of a privatized system. By transferring more costs to seniors, the government saves money.

Another commercial promises “free eyeglasses and free rides,” presumably to doctors’ offices. Yet another tells viewers they “may qualify” to get $144 added back to their Social Security benefits. The Medicare Part B premium for 2021 is $148.50, which is, presumably, what the commercial promises to save those who choose the privatized system.

I suspected those ads were misleading and deceptive come-ons, designed to persuade listeners to make the call. So I made some calls. The toll-free numbers lead to an insurance brokerage firm or agency that apparently has a network of licensed agents located around the country. Callers are asked to give their ZIP code and then are transferred to an agent who can give the “free benefits” review.

I have heard close to 100 Medicare sales pitches over the years and know that those free consultations are meant to result in a sale whether or not the senior needs the insurance or is really getting a better plan.

Seldom is there any talk about making sure people are covered for the huge amounts doctors and hospitals sometimes charge that Medicare doesn’t cover.

What are the trade-offs, for example, between buying an MA plan, which pays those charges after you satisfy a large annual out of pocket maximum — next year $6,700 per person — or buying a traditional Medigap insurance supplement Plan G, which covers those charges right away? A couple with Medicare Advantage could pay as much as $13,400 a year before their plan would pay for anything.

With so many choices, what’s a consumer to do? I rang up Bonnie Burns, one of the best Medicare consumer advocates in the country, for advice.

“It’s just too complicated,” she said. “No wonder people throw up their hands. That’s why people sign up for an Advantage plan with little or no premium and find out what the costs really are as they use benefits through the year.” She added, “It would be so much easier if Medicare Advantage plans and drug plans were standardized so people could figure this out.”

Congress’ decision not to standardize Advantage plans or drug plans has resulted in today’s chaotic marketplace. Congress wanted to allow every insurer in the universe to throw something out there so the companies could make money and could entice more people to leave the traditional Medicare program. The goal was to reduce the costs to the program, all the while side-stepping any action to control runaway medical costs.

One final bit of crucial advice is missing in today’s ads. Even after you enroll in an MA plan, perhaps enticed by a few dollars in savings for a pair of glasses, you can return to traditional Medicare in the future. But in all but four states — New York, Connecticut, Massachusetts, and Maine — state laws prohibit you from buying a Medigap supplement without an insurer scrutinizing your health status.

If you have developed a preexisting condition, you may be ineligible for a Medigap policy. I’ve met many people over the years who bought an Advantage plan, got sick, and needed to go to out-of-network for treatment. They learned the hard way they were shut out of the Medigap market for good.

Trudy Lieberman, a journalist for 40 years, is a fellow at the Center for Advancing Health. She was recently director of the health and medical reporting program at the Graduate School of Journalism, City University of New York and had a long career at Consumer Reports specializing in insurance, health care and health care financing. Send comments to dr-editorial@greenfield reporter.com.